Endoscopic ultrasound-guided radiofrequency ablation of pancreatic insulinoma: a state of the art review

References

• Das S, Epidemiology DA. Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences? Curr Oncol Rep. 2021;23(4):43. doi: 10.1007/s11912-021-01029-7
   PubMed Web of Science ®Google Scholar
• Sonbol MB, Mazza GL, Mi L, et al. Survival and incidence patterns of pancreatic neuroendocrine tumors over the last 2 decades: a SEER database analysis. Oncology. 2022;27(7):573–8. doi: 10.1093/oncolo/oyac049
   Google Scholar
• Hallet J, Law CH, Cukier M, et al. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes. Cancer. 2015;121(4):589–597. doi: 10.1002/cncr.29099
   PubMed Web of Science ®Google Scholar
• Okabayashi T, Shima Y, Sumiyoshi T, et al. Diagnosis and management of insulinoma. World J Gastroenterol. 2013;19(6):829–837. doi: 10.3748/wjg.v19.i6.829
   PubMed Web of Science ®Google Scholar
• Maggio I, Mollica V, Brighi N, et al. The functioning side of the pancreas: a review on insulinomas. J Endocrinol Invest. 2020;43(2):139–48. doi: 10.1007/s40618-019-01091-w
   PubMed Web of Science ®Google Scholar
• Mehrabi A, Fischer L, Hafezi M, et al. A systematic review of localization, surgical treatment options, and outcome of insulinoma. Pancreas. 2014;43(5):675–86. doi: 10.1097/MPA.0000000000000110
   PubMed Web of Science ®Google Scholar
• Falconi M, Eriksson B, Kaltsas G, et al. ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors. Neuroendocrinology. 2016;103(2):153–71. doi: 10.1159/000443171
   PubMed Web of Science ®Google Scholar
• Service FJ, McMahon MM, O’Brien PC, et al. Functioning insulinoma–incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc. 1991;66(7):711–719. doi: 10.1016/S0025-6196(12)62083-7
   PubMed Web of Science ®Google Scholar
• Sakurai A, Yamazaki M, Suzuki S, et al. Clinical features of insulinoma in patients with multiple endocrine neoplasia type 1: analysis of the database of the MEN Consortium of Japan. Endocr J. 2012;59(10):859–66. doi: 10.1507/endocrj.EJ12-0173
   PubMed Web of Science ®Google Scholar
• Zhao Y, Yu J, Liu Y, et al. Analysis of 55 patients with multiple endocrine neoplasia type 1-associated insulinoma from a single center in China. Orphanet J Rare Dis. 2022;17(1):219. doi: 10.1186/s13023-022-02370-1
   PubMed Web of Science ®Google Scholar
• Rostambeigi N, Thompson GB. What should be done in an operating room when an insulinoma cannot be found? Clin Endocrinol (Oxf). 2009;70(4):512–5. doi: 10.1111/j.1365-2265.2009.03527.x
   PubMed Web of Science ®Google Scholar
• Placzkowski KA, Vella A, Thompson GB, et al. Secular trends in the presentation and management of functioning Insulinoma at the Mayo Clinic, 1987–2007. J Clin Endocrinol Metab. 2009;94(4):1069–1073. doi: 10.1210/jc.2008-2031
   PubMed Web of Science ®Google Scholar
• Service FJ, Natt N. The prolonged fast. J Clin Endocrinol Metab. 2000;85(11):3973–4. doi: 10.1210/jcem.85.11.6934
   PubMed Web of Science ®Google Scholar
• Jyotsna VP, Pal S, Kandasamy D, et al. Evolving management of insulinoma: Experience at a tertiary care centre. Indian J Med Res. 2016;144(5):771. doi: 10.4103/ijmr.IJMR_1477_14
   PubMedGoogle Scholar
• Facciorusso A, Bajwa HS, Menon K, et al. Comparison between 22G aspiration and 22G biopsy needles for EUS-guided sampling of pancreatic lesions: a meta-analysis. Endosc Ultrasound. 2020;9(3):167–74. doi: 10.4103/eus.eus_4_19
   PubMed Web of Science ®Google Scholar
• Wang H, Ba Y, Xing Q, et al. Diagnostic value of endoscopic ultrasound for insulinoma localization: a systematic review and meta-analysis. PloS One. 2018;13(10):e0206099. doi: 10.1371/journal.pone.0206099
   PubMed Web of Science ®Google Scholar
• Crippa S, Zerbi A, Boninsegna L, et al. Surgical management of insulinomas: short- and long-term outcomes after enucleations and pancreatic resections. Arch Surg. 2012;147(3):261–266. doi: 10.1001/archsurg.2011.1843
   PubMedGoogle Scholar
• de Carbonnières A, Challine A, Cottereau AS, et al. Surgical management of insulinoma over three decades. HPB (Oxford). 2021;23(12):1799–1806. doi: 10.1016/j.hpb.2021.04.013
   PubMed Web of Science ®Google Scholar
• Jilesen AP, van Eijck CH, in’t Hof KH, et al. Postoperative complications, In-hospital mortality and 5-year survival after surgical resection for patients with a pancreatic neuroendocrine tumor: a systematic review. World J Surg. 2016;40(3):729–748. doi: 10.1007/s00268-015-3328-6
   PubMed Web of Science ®Google Scholar
• Partelli S, Massironi S, Zerbi A, et al. Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial. Br J Surg. 2022;109(12):1186–90. doi: 10.1093/bjs/znac267
   PubMed Web of Science ®Google Scholar
• Sada A, McKenzie TJ, Vella A, et al. Interventional vs surgical procedures in localized/nonmetastatic insulinomas (ablation vs surgery). Endocr Relat Cancer. 2023;30(6):e220362. doi: 10.1530/ERC-22-0362
   PubMed Web of Science ®Google Scholar
• Rimbaş M, Horumbă M, Rizzatti G, et al. Interventional endoscopic ultrasound for pancreatic neuroendocrine neoplasms. Dig Endosc. 2020;32(7):1031–1041. doi: 10.1111/den.13635
   PubMed Web of Science ®Google Scholar
• Marasco M, Galasso D, Larghi A, et al. When should we adopt EUS-Guided radiofrequency ablation in pancreatic neuroendocrine tumors? J Clin Med. 2023;12(14):4581. doi: 10.3390/jcm12144581
   PubMed Web of Science ®Google Scholar
• Hong K, Georgiades C. Radiofrequency ablation: mechanism of action and devices. J Vasc Interv Radiol. 2010;21(8):S179–86. doi: 10.1016/j.jvir.2010.04.008
   PubMed Web of Science ®Google Scholar
• Ahmed M, Brace CL, FT L Jr, et al. Principles of and advances in percutaneous ablation. Radiology. 2011;258(2):351–369. doi: 10.1148/radiol.10081634
   PubMed Web of Science ®Google Scholar
• McGahan JP, Brock JM, Tesluk H, et al. Hepatic ablation with use of radio-frequency electrocautery in the animal model. J Vasc Interv Radiol. 1992;3(2):291–7. doi: 10.1016/S1051-0443(92)72028-4
   PubMedGoogle Scholar
• Lakhtakia S, Seo DW. Endoscopic ultrasonography-guided tumor ablation. Dig Endosc. 2017;29(4):486–494. doi: 10.1111/den.12833
   PubMed Web of Science ®Google Scholar
• Dobbins C, Wemyss-Holden SA, Cockburn J, et al. Bimodal electric tissue ablation-modified radiofrequency ablation with a le veen electrode in a pig model. J Surg Res. 2008;144(1):111–6. doi: 10.1016/j.jss.2007.03.066
   PubMed Web of Science ®Google Scholar
• Lu DS, Raman SS, Limanond P, et al. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol. 2003;14(10):1267–1274. doi: 10.1097/01.RVI.0000092666.72261.6B
   PubMed Web of Science ®Google Scholar
• Gollapudi LA, Tyberg A. EUS-RFA of the pancreas: where are we and future directions. Transl Gastroenterol Hepatol. 2022;7:18. doi:10.21037/tgh-2020-11
   PubMed Web of Science ®Google Scholar
• Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol. 2000;174(2):323–31. doi: 10.2214/ajr.174.2.1740323
   PubMed Web of Science ®Google Scholar
• Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14(3):199–208. doi: 10.1038/nrc3672
   PubMed Web of Science ®Google Scholar
• Haen SP, Pereira PL, Salih HR, et al. More than just tumor destruction: immunomodulation by thermal ablation of cancer. Clin Dev Immunol. 2011;2011:160250. doi: 10.1155/2011/160250
   PubMed Web of Science ®Google Scholar
• Crinò SF, D’Onofrio M, Bernardoni L, et al. EUS-guided radiofrequency ablation (EUS-RFA) of solid pancreatic neoplasm using an 18-gauge needle electrode: feasibility, safety, and technical success. J Gastrointestin Liver Dis. 2018;27(1):67–72. doi: 10.15403/jgld.2014.1121.271.eus
   PubMed Web of Science ®Google Scholar
• Widmann G, Bodner G, Bale R. Tumour ablation: technical aspects. Cancer Imaging. 2009;9 Spec No A(Special issue A):S63–7. doi:10.1102/1470-7330.2009.9026
   PubMedGoogle Scholar
• Goldberg SN. Radiofrequency tumor ablation: principles and techniques. Eur J Ultrasound. 2001;13(2):129–147. doi: 10.1016/S0929-8266(01)00126-4
   PubMedGoogle Scholar
• Lakhtakia S, Ramchandani M, Galasso D, et al. EUS-guided radiofrequency ablation for management of pancreatic insulinoma by using a novel needle electrode (with videos). Gastrointest Endosc. 2016;83(1):234–9. doi: 10.1016/j.gie.2015.08.085
   PubMed Web of Science ®Google Scholar
• Crha M, Hlavsa J, Procházka V, et al. Radiofrequency ablation of pancreas and optimal cooling of peripancreatic tissue in an ex-vivo porcine model. Acta Veterinaria Brno. 2012;80(4):407–413. doi: 10.2754/avb201180040407
   Web of Science ®Google Scholar
• Kim HJ, Seo DW, Hassanuddin A, et al. EUS-guided radiofrequency ablation of the porcine pancreas. Gastrointest Endosc. 2012;76(5):1039–43. doi: 10.1016/j.gie.2012.07.015
   PubMed Web of Science ®Google Scholar
• Song TJ, Seo DW, Lakhtakia S, et al. Initial experience of EUS-guided radiofrequency ablation of unresectable pancreatic cancer. Gastrointest Endosc. 2016;83(2):440–3. doi: 10.1016/j.gie.2015.08.048
   PubMed Web of Science ®Google Scholar
• Facciorusso A, Kovacevic B, Yang D, et al. Predictors of adverse events after endoscopic ultrasound-guided through-the-needle biopsy of pancreatic cysts: a recursive partitioning analysis. Endoscopy. 2022;54(12):1158–68. doi: 10.1055/a-1831-5385
   PubMed Web of Science ®Google Scholar
• Kandula S, Aurangabadker G, Modi V. Management of a difficult case of insulinoma with radiofrequency ablation. Indian J Endocrinol Metabol. 2019;23:S46–S17.
   PubMedGoogle Scholar
• Napoléon B, Lisotti A, Caillol F, et al. Risk factors for EUS-guided radiofrequency ablation adverse events in patients with pancreatic neoplasms: a large national French study (RAFPAN study). Gastrointest Endosc. 2023;98(3):392–399.e1. doi: 10.1016/j.gie.2023.04.003
   PubMed Web of Science ®Google Scholar
• Choi JH, Seo DW, Song TJ, et al. Utility of Contrast-Enhanced Harmonic Endoscopic Ultrasound for the guidance and monitoring of Endoscopic radiofrequency ablation. Gut Liver. 2020;14(6):826–32. doi: 10.5009/gnl19123
   PubMed Web of Science ®Google Scholar
• Lisotti A, Napoleon B, Facciorusso A, et al. Contrast-enhanced EUS for the characterization of mural nodules within pancreatic cystic neoplasms: systematic review and meta-analysis. Gastrointest Endosc. 2021;94(5):881–889.e5. doi: 10.1016/j.gie.2021.06.028
   PubMed Web of Science ®Google Scholar
• Facciorusso A, Mohan BP, Crinò SF, et al. Contrast-enhanced harmonic endoscopic ultrasound-guided fine-needle aspiration versus standard fine-needle aspiration in pancreatic masses: a meta-analysis. Expert Rev Gastroenterol Hepatol. 2021;15(7):821–8. doi: 10.1080/17474124.2021.1880893
   PubMed Web of Science ®Google Scholar
• Arcidiacono PG, Carrara S, Reni M, et al. Feasibility and safety of EUS-guided cryothermal ablation in patients with locally advanced pancreatic cancer. Gastrointest Endosc. 2012;76(6):1142–51. doi: 10.1016/j.gie.2012.08.006
   PubMed Web of Science ®Google Scholar
• Elkelany OO, Karaisz FG, Davies B, et al. An overview of pancreatic neuroendocrine tumors and an update on Endoscopic Techniques for their management. Curr Oncol. 2023;30(8):7566–80. doi: 10.3390/curroncol30080549
   PubMed Web of Science ®Google Scholar
• Larghi A, Rizzatti G, Rimbaş M, et al. EUS-guided radiofrequency ablation as an alternative to surgery for pancreatic neuroendocrine neoplasms: who should we treat? Endosc Ultrasound. 2019;8(4):220–6. doi: 10.4103/eus.eus_28_19
   PubMed Web of Science ®Google Scholar
• Testoni SGG, Healey AJ, Dietrich CF, et al. Systematic review of endoscopy ultrasound-guided thermal ablation treatment for pancreatic cancer. Endosc Ultrasound. 2020;9(2):83–100. doi: 10.4103/eus.eus_74_19
   PubMed Web of Science ®Google Scholar
• Goldberg SN, Mallery S, Gazelle GS, et al. EUS-guided radiofrequency ablation in the pancreas: results in a porcine model. Gastrointest Endosc. 1999;50(3):392–401. doi: 10.1053/ge.1999.v50.98847
   PubMed Web of Science ®Google Scholar
• Carrara S, Arcidiacono PG, Albarello L, et al. Endoscopic ultrasound-guided application of a new hybrid cryotherm probe in porcine pancreas: a preliminary study. Endoscopy. 2008;40(4):321–6. doi: 10.1055/s-2007-995595
   PubMed Web of Science ®Google Scholar
• Gaidhane M, Smith I, Ellen K, et al. Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) of the pancreas in a porcine Model. Gastroenterol Res Pract. 2012;2012:431451. doi: 10.1155/2012/431451
   PubMed Web of Science ®Google Scholar
• Garg R, Mohammed A, Singh A, et al. EUS-guided radiofrequency and ethanol ablation for pancreatic neuroendocrine tumors: a systematic review and meta-analysis. Endosc Ultrasound. 2022;11(3):170–85. doi: 10.4103/EUS-D-21-00044
   PubMed Web of Science ®Google Scholar
• Imperatore N, de Nucci G, Mandelli ED, et al. Endoscopic ultrasound-guided radiofrequency ablation of pancreatic neuroendocrine tumors: a systematic review of the literature. Endosc Int Open. 2020;8(12):E1759–E1764. doi: 10.1055/a-1261-9605
   PubMedGoogle Scholar
• Khoury T, Sbeit W, Fusaroli P, et al. Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine neoplasms: systematic review and meta-analysis. Dig Endosc. 2023 Sep 13. doi: 10.1111/den.14681
   PubMedGoogle Scholar
• Armellini E, Facciorusso A, Crinò SF. Efficacy and safety of endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine tumors: a systematic review and Metanalysis. Medicina (Kaunas). 2023;59(2):359. doi: 10.3390/medicina59020359
   PubMed Web of Science ®Google Scholar
• Fahmawi Y, Mehta A, Abdalhadi H, et al. Efficacy and safety of endoscopic ultrasound-guided radiofrequency ablation for management of pancreatic lesions: a systematic review and meta-analysis. Transl Gastroenterol Hepatol. 2022;7:30. doi: 10.21037/tgh-20-84
   PubMed Web of Science ®Google Scholar
• Dhaliwal A, Kolli S, Dhindsa BS, et al. Efficacy of EUS-RFA in pancreatic tumors: is it ready for prime time? A systematic review and meta-analysis. Endosc Int Open. 2020;8(10):E1243–E1251. doi: 10.1055/a-1221-5012
   PubMedGoogle Scholar
• El Sayed G, Frim L, Franklin J, et al. Endoscopic ultrasound-guided ethanol and radiofrequency ablation of pancreatic insulinomas: a systematic literature review. Therap Adv Gastroenterol. 2021;14:17562848211042171. doi: 10.1177/17562848211042171
   Web of Science ®Google Scholar
• Rossi S, Viera FT, Ghittoni G, et al. Radiofrequency ablation of pancreatic neuroendocrine tumors: a pilot study of feasibility, efficacy, and safety. Pancreas. 2014;43(6):938–45. doi: 10.1097/MPA.0000000000000133
   PubMed Web of Science ®Google Scholar
• Pai M, Habib N, Senturk H, et al. Endoscopic ultrasound guided radiofrequency ablation, for pancreatic cystic neoplasms and neuroendocrine tumors. World J Gastrointest Surg. 2015;7(4):52–59. doi: 10.4240/wjgs.v7.i4.52
   PubMedGoogle Scholar
• Choi JH, Seo DW, Song TJ, et al. Endoscopic ultrasound-guided radiofrequency ablation for management of benign solid pancreatic tumors. Endoscopy. 2018;50(11):1099–1104. doi: 10.1055/a-0583-8387
   PubMed Web of Science ®Google Scholar
• Chang JY, Woo CS, Lui DT, et al. Case report: insulinoma Co-existing with type 2 diabetes – advantages and challenges of treatment with endoscopic ultrasound-guided radiofrequency ablation. Front Endocrinol. 2022;13:957369. doi: 10.3389/fendo.2022.957369
   PubMed Web of Science ®Google Scholar
• Brown NG, Patel AA, Gonda TA. Immediate and durable therapeutic response after EUS-guided radiofrequency ablation of a pancreatic insulinoma. VideoGIE. 2020;5(12):676–78. doi: 10.1016/j.vgie.2020.07.021
   PubMedGoogle Scholar
• Jonica ER, Wagh MS. Endoscopic treatment of symptomatic insulinoma with a new EUS-guided radiofrequency ablation device. VideoGIE. 2020;5(10):483–5. doi: 10.1016/j.vgie.2020.05.028
   PubMedGoogle Scholar
• Bas-Cutrina F, Bargalló D, Gornals JB. Small pancreatic insulinoma: successful endoscopic ultrasound-guided radiofrequency ablation in a single session using a 22-G fine needle. Dig Endosc. 2017;29(5):636–638. doi: 10.1111/den.12866
   PubMed Web of Science ®Google Scholar
• Waung JA, Todd JF, Keane MG, et al. Successful management of a sporadic pancreatic insulinoma by endoscopic ultrasound-guided radiofrequency ablation. Endoscopy. 2016;48(Suppl 1):E144–5. doi: 10.1055/s-0042-104650
   PubMedGoogle Scholar
• Kluz M, Staroń R, Krupa Ł, et al. Successful endoscopic ultrasound-guided radiofrequency ablation of a pancreatic insulinoma. Pol Arch Intern Med. 2020;130:145–146. doi: 10.20452/pamw.15100
   PubMedGoogle Scholar
• Younis F, Ben-Ami Shor D, Lubezky N, et al. Endoscopic ultrasound-guided radiofrequency ablation of premalignant pancreatic-cystic neoplasms and neuroendocrine tumors: prospective study. Eur J Gastroenterol Hepatol. 2022;34(11):1111–5. doi: 10.1097/MEG.0000000000002422
   PubMed Web of Science ®Google Scholar
• Oleinikov K, Dancour A, Epshtein J, et al. Endoscopic ultrasound-guided radiofrequency ablation: a new therapeutic approach for pancreatic neuroendocrine tumors. J Clin Endocrinol Metab. 2019;104(7):2637–47. doi: 10.1210/jc.2019-00282
   PubMed Web of Science ®Google Scholar
• Crinò SF, Napoleon B, Facciorusso A, et al. Endoscopic ultrasound-guided radiofrequency ablation versus surgical resection for treatment of pancreatic insulinoma. Clin Gastroenterol Hepatol. 2023;21(11):2834–2843.e2. doi: 10.1016/j.cgh.2023.02.022
   PubMed Web of Science ®Google Scholar
• Rossi G, Petrone MC, Capurso G, et al. Endoscopic ultrasound radiofrequency ablation of pancreatic insulinoma in elderly patients: three case reports. World J Clin Cases. 2022;10(19):6514–9. doi: 10.12998/wjcc.v10.i19.6514
   PubMed Web of Science ®Google Scholar
• de Nucci G, Imperatore N, Mandelli ED, et al. Endoscopic ultrasound-guided radiofrequency ablation of pancreatic neuroendocrine tumors: a case series. Endosc Int Open. 2020;8(12):E1754–E1758. doi: 10.1055/a-1261-9359
   PubMedGoogle Scholar
• Figueiredo Ferreira M, Garces-Duran R, Eisendrath P, et al. EUS-guided radiofrequency ablation of pancreatic/peripancreatic tumors and oligometastatic disease: an observational prospective multicenter study. Endosc Int Open. 2022;10(10):E1380–E1385. doi: 10.1055/a-1922-4536
   PubMed Web of Science ®Google Scholar
• Marx M, Trosic-Ivanisevic T, Caillol F, et al. EUS-guided radiofrequency ablation for pancreatic insulinoma: experience in 2 tertiary centers. Gastrointest Endosc. 2022;95(6):1256–63. doi: 10.1016/j.gie.2021.11.045
   PubMed Web of Science ®Google Scholar
• de Andreis F B, Boškoski I, Mascagni P, et al. Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: a single-center experience. Pancreatology. 2023;23(5):543–549. S1424-3903(23)00141-2. doi: 10.1016/j.pan.2023.05.004
   PubMed Web of Science ®Google Scholar
• Furnica RM, Deprez P, Maiter D, et al. Endoscopic ultrasound-guided radiofrequency ablation: an effective and safe alternative for the treatment of benign insulinoma. Ann Endocrinol (Paris). 2020;81(6):567–71. doi: 10.1016/j.ando.2020.11.009
   PubMed Web of Science ®Google Scholar
• Debraine Z, Borbath I, Deprez P, et al. Long-term clinical and radiological outcomes of endoscopic ultrasound-guided radiofrequency ablation of benign insulinomas. Clin Endocrinol (Oxf). 2023 Oct 20. doi: 10.1111/cen.14981
   PubMed Web of Science ®Google Scholar
• Thosani N, Cen P, Rowe J, et al. Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) for advanced pancreatic and periampullary adenocarcinoma. Sci Rep. 2022;12(1):16516. doi: 10.1038/s41598-022-20316-2
   PubMed Web of Science ®Google Scholar
• Fegrachi S, Besselink MG, van Santvoort HC, et al. Radiofrequency ablation for unresectable locally advanced pancreatic cancer: a systematic review. HPB (Oxford). 2014;16(2):119–123. doi: 10.1111/hpb.12097
   PubMed Web of Science ®Google Scholar
• Saini M, Samanta J, Kumar A, et al. Buprenorphine versus diclofenac for pain relief in acute pancreatitis: a double-blinded randomized controlled trial. Clin Gastroenterol Hepatol. 2023 Nov 3. S1542-3565(23)00864-9. doi: 10.1016/j.cgh.2023.10.021
   Google Scholar
• Giardino A, Innamorati G, Ugel S, et al. Immunomodulation after radiofrequency ablation of locally advanced pancreatic cancer by monitoring the immune response in 10 patients. Pancreatology. 2017;17(6):962–6. doi: 10.1016/j.pan.2017.09.008
   PubMed Web of Science ®Google Scholar
• Dhar J, Gupta P, Samanta J. The role of endoscopy in malignant hilar obstruction. Ann Gastroenterol. 2023;36:347–359. doi:10.20524/aog.2023.0810
   PubMed Web of Science ®Google Scholar
• Barthet M, Giovannini M, Gasmi M, et al. Long-term outcome after EUS-guided radiofrequency ablation: prospective results in pancreatic neuroendocrine tumors and pancreatic cystic neoplasms. Endosc Int Open. 2021;9(8):E1178–E1185. doi: 10.1055/a-1479-2199
   PubMedGoogle Scholar
• Samanta J, Sundaram S, Dhar J, et al. EUS-guided biliary drainage in patients with moderate–severe cholangitis is safe and effective: a multi-center experience. Surg Endosc. 2023;37(1):298–308. doi: 10.1007/s00464-022-09495-1
   PubMed Web of Science ®Google Scholar
• Melita G, Pallio S, Tortora A, et al. Diagnostic and interventional role of endoscopic ultrasonography for the management of pancreatic neuroendocrine neoplasms. J Clin Med. 2021;10(12):2638. doi: 10.3390/jcm10122638
   PubMed Web of Science ®Google Scholar
• Giuliani T, Marchegiani G, Girgis MD, et al. Endoscopic placement of pancreatic stent for “deep” pancreatic enucleations operative technique and preliminary experience at two high-volume centers. Surg Endosc. 2020;34(6):2796–2802. doi: 10.1007/s00464-020-07501-y
   PubMed Web of Science ®Google Scholar
• Paiella S, Landoni L, Tebaldi S, et al. Dual-tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT scan and G1-G2 nonfunctioning pancreatic neuroendocrine tumors: a single-center retrospective evaluation of 124 nonmetastatic resected cases. Neuroendocrinology. 2022;112(2):143–52. doi: 10.1159/000514809
   PubMed Web of Science ®Google Scholar
• Samanta J, Dhar J, Muktesh G, et al. Endoscopic drainage versus percutaneous drainage for the management of infected walled-off necrosis: a comparative analysis. Expert Rev Gastroenterol Hepatol. 2022;16(3):297–305. doi: 10.1080/17474124.2022.2047649
   PubMed Web of Science ®Google Scholar
• Tacelli M, Bina N, Crinò SF, et al. Reliability of grading preoperative pancreatic neuroendocrine tumors on EUS specimens: a systematic review with meta-analysis of aggregate and individual data. Gastrointest Endosc. 2022;96(6):898–908.e23. doi: 10.1016/j.gie.2022.07.014
   PubMed Web of Science ®Google Scholar
• Samanta J, Nabi Z, Facciorusso A, et al. EUS-guided coil and glue injection versus endoscopic glue injection for gastric varices: international multicentre propensity-matched analysis. Liver Int. 2023;43(8):1783–92. doi: 10.1111/liv.15630
   PubMed Web of Science ®Google Scholar
• Câmara-de-Souza AB, Toyoshima MTK, Giannella ML, et al. Insulinoma: a retrospective study analyzing the differences between benign and malignant tumors. Pancreatology. 2018;18(3):298–303. doi: 10.1016/j.pan.2018.01.009
   PubMed Web of Science ®Google Scholar
• Sada A, Yamashita TS, Glasgow AE, et al. Comparison of benign and malignant insulinoma. Am J Surg. 2021;221(2):437–47. doi: 10.1016/j.amjsurg.2020.08.003
   PubMed Web of Science ®Google Scholar
• Dhar J, Samanta J. Endoscopic ultrasound-guided vascular interventions: an expanding paradigm. World J Gastrointest Endosc. 2023;15(4):216–39. doi: 10.4253/wjge.v15.i4.216
   PubMed Web of Science ®Google Scholar
• Crinò SF, Partelli S, Napoleon B, et al. Study protocol for a multicenter randomized controlled trial to compare radiofrequency ablation with surgical resection for treatment of pancreatic insulinoma. Dig Liver Dis. 2023;55(9):1187–1193. doi: 10.1016/j.dld.2023.06.021
   PubMedGoogle Scholar
• Hackeng WM, Brosens LAA, Dreijerink KMA. Aggressive versus indolent insulinomas: new clinicopathological insights. Endocr Relat Cancer. 2023;30(5):e220321. doi: 10.1530/ERC-22-0321
   PubMed Web of Science ®Google Scholar
• Mastrosimini MG, Manfrin E, Remo A, et al. Endoscopic ultrasound fine-needle biopsy to assess DAXX/ATRX expression and alternative lengthening of telomeres status in non-functional pancreatic neuroendocrine tumors. Pancreatology. 2023;23(4):429–36. doi: 10.1016/j.pan.2023.05.002
   PubMed Web of Science ®Google Scholar
• Crinò SF, Conti Bellocchi MC, Bernardoni L, et al. Diagnostic yield of EUS-FNA of small (≤15 mm) solid pancreatic lesions using a 25-gauge needle. Hepatobiliary Pancreat Dis Int. 2018;17(1):70–74. doi: 10.1016/j.hbpd.2018.01.010
   PubMed Web of Science ®Google Scholar